Table 1. Open in new tab CLSI and EUCAST...

	MIC (mg/L)
CLSI^a	≤64	128	≥256
EUCAST^b	≤8	NA	>8

	MIC (mg/L)
CLSI^a	≤64	128	≥256
EUCAST^b	≤8	NA	>8

Table 1.

CLSI and EUCAST breakpoints for oral and intravenous (IV) fosfomycin formulations

	MIC (mg/L)
	Susceptible	Intermediate	Resistant
CLSI^a	≤64	128	≥256
EUCAST^b	≤8	NA	>8

	MIC (mg/L)
CLSI^a	≤64	128	≥256
EUCAST^b	≤8	NA	>8

^aCLSI M100, Thirty-Fourth Edition applies only to E. coli from the urinary tract and E. faecalis.

^bEUCAST oral breakpoints apply only to uncomplicated UTI caused by E. coli; intravenous breakpoints only E. coli infections originating in the urinary tract.

This Feature Is Available To Subscribers Only